Grieve Out as Zenabis Global CEO, Replaced by Former CEO Kevin Coft

The Board of Directors at Zenabis Global (TSX: ZENA) appear to be dissatisfied with the equities performance to date. This morning, the firm announced that current chief executive Andrew Grieve would be replaced immediately by former CEO Kevin Coft, who will act in the role on an interim basis. Zenabis aims to have a permanent replacement in the role by the end of the first quarter of 2020.

The replacement of Grieve, according to the company, is predicated on his contract being set to expire shortly. However, this is a highly questionable statement, given that his performance incentive payment is highly based on the earnings before interest, tax, depreciation and amortization (EBITDA) of Zenabis Global in 2020, with the payout slated to occur between June 2021 and March 2022. No further information related to his employment contract could be found via Sedar.

Grieve will remain on the Board of Directors, from which he will continue to provide advisory services.

Coft, who will be replacing Grieve on an interim basis was the former CEO of Zenabis Global prior to its merger with Bevo Agro. Currently, he serves as the Chief Facilities Officer for Zenabis, and is responsible for the build out of the firms numerous facilities across Canada.

Zenabis has enlisted Korn Ferry to assist the firm in finding a suitable permanent replacement for the role of chief executive officer at the firm. A final decision for Grieve’s replacement is anticipated to be made in the first quarter of 2020.

Zenabis Global last traded at $0.18 on the TSX.


Information for this briefing was found via Sedar and Zenabis Global. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

This Gold Story Starts With Cash Flow | Gordon Robb – ESGold

Silverco Cusi Mine PEA: Bigger Isn’t Always Better

Fixing Heart Disease Tied to Sudden Death in Young People | David Elsley – Cardiol Therapeutics

Recommended

Cambria Drills 17.95 g/t Gold Over 22 Metres At Premier Mine

Denarius Metals Increases Bid For Emerita Resources To $0.45 Per Share

Related News

Zenabis Announces Cannabis Infused Beverage Production Arrangement

Zenabis Global (TSX: ZENA) this morning released an update related to its second generation cannabis...

Wednesday, February 19, 2020, 08:40:15 AM

Zenabis Revenues Decline 13% In Third Quarter, Posts Net Loss Of $17.0 Million

Zenabis Global (TSX: ZENA) this morning released its third quarter 2020 financial results, reporting revenues...

Friday, November 13, 2020, 10:06:52 AM

Zenabis Fails EU-GMP Certification at Delta Facility

Zenabis Global (TSX: ZENA) failed a facility inspection at its Delta, BC location for EU-GMP...

Thursday, December 5, 2019, 11:39:58 AM

Zenabis Reports Q4 Revenues Of $15.9 Million, Net Loss Of $30.1 Million

Zenabis Global (TSX: ZENA) last night quietly filed its fourth quarter and full year 2020...

Thursday, April 1, 2021, 07:11:14 AM

Hexo Corp Sees Zenabis Subsidiary File For CCAA Protection Due To Sundial Growers Debt

If you thought Hexo Corp (TSX: HEXO) was a mess before, buckle up as it...

Friday, June 17, 2022, 08:16:55 AM